(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported that on (b)(6) 2016, a 2.75x28 rx xience alpine and a 3.0x23 rx xience alpine drug-eluting stent were implanted for treatment of an unspecified vessel.On (b)(6) 2016, the patient was rehospitalized due to other unspecified cardiovascular symptoms and sepsis.Unspecified treatment was administered and the final patient outcome is reportedly unknown.No additional information was provided.
|